Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Barrett Esophagus × X-Rays × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinosarcoma 2 Brain Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Intraductal Neoplasms 1 Ovarian Neoplasms 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Locally Advanced Cervical Adenocarcinoma 1 Liposarcoma 1 Histiocytoma, Malignant Fibrous 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Burkitt Lymphoma 1 Barrett Esophagus 1 Anus Neoplasms 1 Anal Canal Carcinoma 1 Adenoma, Islet Cell 1

Interventions

X-Rays 1 Omeprazole 1 Melatonin 1 Esomeprazole 1 Endoscopy, Digestive System 1 Endoscopy 1 Blood Specimen Collection 1 Biopsy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡